Michael Chisamore - Dissemin

Language
Login

All papers authored by Michael Chisamore

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

ORCID

, Niels Junker, Michael Chisamore

ORCID

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

ORCID

, William D. Tap

Table S4 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

ORCID

, Niels Junker, Michael Chisamore

ORCID

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

ORCID

, William D. Tap

Figure S2 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

ORCID

, Niels Junker, Michael Chisamore

ORCID

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

ORCID

, William D. Tap

Figure S1 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

ORCID

, Niels Junker, Michael Chisamore

ORCID

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

ORCID

, William D. Tap

Data from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

ORCID

, Niels Junker, Michael Chisamore

ORCID

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

ORCID

, William D. Tap

Table S2 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

ORCID

, Niels Junker, Michael Chisamore

ORCID

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

ORCID

, William D. Tap

Table S1 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Patrick Schöffski, Rastislav Bahleda, Andrew J. Wagner, Melissa A. Burgess

ORCID

, Niels Junker, Michael Chisamore

ORCID

, Patrick Peterson, Anna M. Szpurka, Matteo Ceccarelli

ORCID

, William D. Tap

Table S3 from Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Upload

Missing publications? Search for publications with a matching author name.